Related Experiment Videos
Monoclonal antibodies in the treatment of malignant melanoma
1ABTEK, Tiburon, Calif.
Frontiers of Radiation Therapy and Oncology
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma.
Critical reviews in oncology/hematology·2001
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma.
Cancer biotherapy & radiopharmaceuticals·2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Oil-in-water liposomal emulsions: characterization and potential use in vaccine delivery.
Journal of pharmaceutical sciences·1999
Immunologic approaches to the treatment of prostate cancer.
Seminars in oncology·1999
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011